Granulocyte Colony-stimulating Factor in the Treatment of Acute Radiation Syndrome: a Concise Review

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2014 Apr 19

PMID 24743934

Citations 9

Authors

Michal Hofer

Milan Pospisil

Denisa Komurkova

Zuzana Hoferova

Affiliations

Soon will be listed here.

Abstract

This article concisely summarizes data on the action of one of the principal and best known growth factors, the granulocyte colony-stimulating factor (G-CSF), in a mammalian organism exposed to radiation doses inducing acute radiation syndrome. Highlighted are the topics of its real or anticipated use in radiation accident victims, the timing of its administration, the possibilities of combining G-CSF with other drugs, the ability of other agents to stimulate endogenous G-CSF production, as well as of the capability of this growth factor to ameliorate not only the bone marrow radiation syndrome but also the gastrointestinal radiation syndrome. G-CSF is one of the pivotal drugs in the treatment of radiation accident victims and its employment in this indication can be expected to remain or even grow in the future.

Citing Articles

Multiwell-based G0-PCC assay for radiation biodosimetry.

Royba E, Shuryak I, Ponnaiya B, Repin M, Pampou S, Karan C Sci Rep. 2024; 14(1):19789.

PMID: 39187542 PMC: 11347619. DOI: 10.1038/s41598-024-69243-4.

Bone marrow vasculature advanced models for cancer and cardiovascular research.

Campanile M, Bettinelli L, Cerutti C, Spinetti G Front Cardiovasc Med. 2023; 10:1261849.

PMID: 37915743 PMC: 10616801. DOI: 10.3389/fcvm.2023.1261849.

Validation of a High-Throughput Dicentric Chromosome Assay Using Complex Radiation Exposures.

Royba E, Repin M, Balajee A, Shuryak I, Pampou S, Karan C Radiat Res. 2022; 199(1):1-16.

PMID: 35994701 PMC: 9947868. DOI: 10.1667/RADE-22-00007.1.

Preclinical Studies and Clinical Prospects of Wharton's Jelly-Derived MSC for Treatment of Acute Radiation Syndrome.

Bandekar M, Maurya D, Sharma D, Sandur S Curr Stem Cell Rep. 2021; 7(2):85-94.

PMID: 33936933 PMC: 8080090. DOI: 10.1007/s40778-021-00188-4.

Allogeneic adipose-derived stem cells mitigate acute radiation syndrome by the rescue of damaged bone marrow cells from apoptosis.

Chinnapaka S, Yang K, Samadi Y, Epperly M, Hou W, Greenberger J Stem Cells Transl Med. 2021; 10(7):1095-1114.

PMID: 33724714 PMC: 8235137. DOI: 10.1002/sctm.20-0455.

References

Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A . Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Exp Hematol. 2002; 30(12):1390-8. DOI: 10.1016/s0301-472x(02)00962-1. View

Singh V, Ducey E, Brown D, Whitnall M . A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol. 2011; 88(4):296-310. DOI: 10.3109/09553002.2012.652726. View

Hoggatt J, Pelus L . New G-CSF agonists for neutropenia therapy. Expert Opin Investig Drugs. 2013; 23(1):21-35. DOI: 10.1517/13543784.2013.838558. View

Singh V, Grace M, Parekh V, Whitnall M, Landauer M . Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice. Int Immunopharmacol. 2009; 9(12):1401-10. DOI: 10.1016/j.intimp.2009.08.012. View

Herodin F, Drouet M . Myeloprotection following cytotoxic damage: the sooner the better. Exp Hematol. 2008; 36(7):769-70. DOI: 10.1016/j.exphem.2008.02.005. View

Waselenko J, MacVittie T, Blakely W, Pesik N, Wiley A, Dickerson W . Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004; 140(12):1037-51. DOI: 10.7326/0003-4819-140-12-200406150-00015. View

Farese A, Cohen M, Stead R, Jackson 3rd W, MacVittie T . Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques. Radiat Res. 2012; 178(5):403-13. DOI: 10.1667/RR2900.1. View

Sureda A, Valls A, Kadar E, Algara M, Bigas A, Jaume M . A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice. Exp Hematol. 1993; 21(12):1605-7. View

Singh P, Wise S, Ducey E, Brown D, Singh V . Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 2011; 56(2):411-21. DOI: 10.1016/j.cyto.2011.08.016. View

10.

Metcalf D, Nicola N . Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J Cell Physiol. 1983; 116(2):198-206. DOI: 10.1002/jcp.1041160211. View

11.

Moroni M, Ngudiankama B, Christensen C, Olsen C, Owens R, Lombardini E . The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation. Int J Radiat Oncol Biol Phys. 2013; 86(5):986-92. PMC: 3710733. DOI: 10.1016/j.ijrobp.2013.04.041. View

12.

Farese A, Cohen M, Katz B, Smith C, Gibbs A, Cohen D . Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 2012; 179(1):89-100. PMC: 4562422. DOI: 10.1667/RR3049.1. View

13.

Farese A, Hunt P, Grab L, MacVittie T . Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 1996; 97(9):2145-51. PMC: 507290. DOI: 10.1172/JCI118652. View

14.

MacVittie T, Monroy R, Patchen M, Souza L . Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol. 1990; 57(4):723-36. DOI: 10.1080/09553009014550891. View

15.

Pellmar T, Rockwell S . Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res. 2004; 163(1):115-23. DOI: 10.1667/rr3283. View

16.

Singh V, Shafran R, Inal C, Jackson 3rd W, Whitnall M . Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol. 2006; 27(4):521-34. DOI: 10.1080/08923970500416707. View

17.

Gourmelon P, Benderitter M, Bertho J, Huet C, Gorin N, De Revel P . European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys. 2010; 98(6):825-32. DOI: 10.1097/HP.0b013e3181ce64d4. View

18.

Farese A, Cohen M, Katz B, Smith C, Jackson 3rd W, Cohen D . A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 2012; 103(4):367-82. PMC: 3877682. DOI: 10.1097/HP.0b013e31825f75a7. View

19.

Pospisil M, Hofer M, Znojil V, Netikova J, Vacha J, Hola J . Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur J Haematol. 1998; 60(3):172-80. DOI: 10.1111/j.1600-0609.1998.tb01019.x. View

20.

Drouet M, Delaunay C, Grenier N, Garrigou P, Mayol J, Herodin F . Cytokines in combination to treat radiation-induced myelosuppresssion: evaluation of SCF + glycosylated EPO + pegylated G-CSF as an emergency treatment in highly irradiated monkeys. Haematologica. 2008; 93(3):465-6. DOI: 10.3324/haematol.12183. View